|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0038952,
umls-concept:C0184511,
umls-concept:C0205146,
umls-concept:C0205208,
umls-concept:C0206624,
umls-concept:C0684224,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1521725,
umls-concept:C1527178,
umls-concept:C1705938,
umls-concept:C2603343,
umls-concept:C2698651
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-17
|
|
pubmed:abstractText |
The survival outcome for patients with hepatoblastoma normally depends on the resectability of the tumor. In Japan, the pre and/or postoperative chemotherapy protocol using a combination of cisplatin (CDDP) and tetrahydropyranyl-Adriamycin (THP-ADR) has been the standard treatment since 1991. This study aims to assess exactly what influence the establishment of this chemotherapy protocol has had on both the tumor resectability and the outcome of patients with hepatoblastoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1531-5037
|
|
pubmed:author |
pubmed-author:Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan,
pubmed-author:EguchiHH,
pubmed-author:HaraTT,
pubmed-author:InomataYY,
pubmed-author:KawakamiKK,
pubmed-author:MiyazakiSS,
pubmed-author:MizoteHH,
pubmed-author:NagasakiAA,
pubmed-author:OkamuraJJ,
pubmed-author:SuitaSS,
pubmed-author:TajiriTT,
pubmed-author:TakamatsuHH,
pubmed-author:TsuneyoshiMM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-8; discussion 195-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14966739-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14966739-Child,
pubmed-meshheading:14966739-Child, Preschool,
pubmed-meshheading:14966739-Combined Modality Therapy,
pubmed-meshheading:14966739-Drug Evaluation,
pubmed-meshheading:14966739-Embolization, Therapeutic,
pubmed-meshheading:14966739-Female,
pubmed-meshheading:14966739-Hepatectomy,
pubmed-meshheading:14966739-Hepatoblastoma,
pubmed-meshheading:14966739-Humans,
pubmed-meshheading:14966739-Infant,
pubmed-meshheading:14966739-Infant, Newborn,
pubmed-meshheading:14966739-Japan,
pubmed-meshheading:14966739-Liver Neoplasms,
pubmed-meshheading:14966739-Male,
pubmed-meshheading:14966739-Neoplasm Staging,
pubmed-meshheading:14966739-Registries,
pubmed-meshheading:14966739-Retrospective Studies,
pubmed-meshheading:14966739-Survival Analysis,
pubmed-meshheading:14966739-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
|
|
pubmed:affiliation |
Department of Pediatric Surgery, Kyushu University, Kyushu, Japan.
|
|
pubmed:publicationType |
Journal Article,
Review,
Multicenter Study
|
